UTHR

United Therapeutics Corporation (UTHR)

Last Price$365.0(0.4%)
Market Cap$16.2B
LTM Gross margin
88.9%
5Y avg
91.5%
Biotechnology industry median
65.9%
Stock quality & Intrinsic value
8/10
0.2% undervalued

United Therapeutics Corporation Gross margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
UTHR
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Gross margin
88.8%
89.4%
89.3%
89.4%
89.3%
87.7%
87.8%
88.0%
87.0%
88.3%
90.2%
95.3%
95.5%
93.9%
87.8%
91.9%
92.7%
92.7%
92.4%
88.9%
UTHR
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for UTHR and see if it's the right time to invest.
Dive in

United Therapeutics Corporation (UTHR) Gross margin comparison analysis

Crunching data... Almost there!

UTHR key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is United Therapeutics Corporation's Gross margin?

As of today, Microsoft Corp's last 12-month Gross margin is 88.9%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Gross margin for United Therapeutics Corporation have been 91.2% over the past three years, and 96.1% over the past five years.

2) Is United Therapeutics Corporation's Gross margin Good?

As of today, United Therapeutics Corporation's Gross margin is 88.9%, which is higher than industry median of 65.9%. It indicates that United Therapeutics Corporation's Gross margin is Good.

3) How does United Therapeutics Corporation's Gross margin compare to its peers?

As of today, United Therapeutics Corporation's Gross margin is 88.9%, which is higher than peer median of 85.0%. The list of peers includes GMAB, INCY, ARGX, VRTX, ALNY, NVO, REGN, BNTX, BGNE, MRNA.